Academia
Researchers have now identified one pathway that lung cancer cells use to avoid chemotherapy, which may lead to new approaches for treatment.
Researchers at Vanderbilt University recently studied the inflammation phase after heart attacks and identified a protein, cadherin-11, that is significantly involved in the inflammation in cardiac fibrosis.
South San Francisco-based Allogene Therapeutics inked a research collaboration deal with Stanford University to work on a novel nucleic acid delivery system for CAR-T therapy.
Biotech and pharma companies from across the globe strengthen their leadership teams and boards of directors with this week’s appointments.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Working with a new class of cancer drugs called G12C KRAS inhibitors, researchers at the Francis Crick Institute and The Institute of Cancer Research (ICR), London, developed drug combinations to stay ahead of drug resistant tumors.
Researchers at the University of Missouri-Columbia, utilized CRISPR gene editing in a mouse model, to edit out the gene mutation and transplant AAV9 treated muscle into the mice.
Crescendo Biologics Ltd announces that it has signed collaborations with world-renowned oncology research groups at the University of Oxford and the University of Surrey.
Collaborating researchers at the University of Iowa and Capital Medical University in Beijing, China, found that a drug used to treat enlarged prostate, terazosin, appears able to slow the progress of Parkinson’s disease.
A University of Houston chemist is exploring the link between copper protein molecules in brain cells and their link to neurodegenerative diseases like Alzheimer’s.
PRESS RELEASES